Irene (Pyrotinib)

Inquire / Price
  • Model Number:
    RL2320241030400
  • Brand Name:
    Irene (艾瑞妮)
  • Origin:
    Original invention from China
  • Small Orders:
    Small batches also available
  • Tags:
Inquire Now Link

Poster
  • Details
  • Description
  • Packaging Size
    100t
  • Strength
    80mg
  • Compositon
    Pyrotinib
  • Treatment
    HER2-positive breast cancer
  • Form
    Tablet
  • Brand
    Irene (艾瑞妮)
  • Quantity Unit
    80mg*100t/Bottle
  • Manufacturer
    Jiangsu Hengrui Medicine.china

About Pyrotinib

Irene (Pyrotinib) sold under the brand name 艾瑞妮 in china, Pyrotinib is an irreversible dual pan-ErbB receptor tyrosine kinase inhibitor developed for the treatment of HER2-positive advanced solid tumours. 

Approval

Based on this phase II study, pyrotinib in combination with capecitabine received its first conditional approval in China for the treatment of HER2-positive, advanced or metastatic breast cancer previously exposed to anthracycline or taxane chemotherapy. 

Dosage

Depending on the indication, pyrotinib is taken orally at a standard dose of 400 mg/day. Dosage adjustments, combination, or non-combination of any antineoplastic agents are considered according to the physician's decision-making, the patient's previous treatment regimen, and the patient's own circumstances and wishes.


Link

Poster

Top